APA (7th ed.) Citation

Gao, S., Li, N., Gao, S., Xue, Q., Ying, J., Wang, S., . . . He, J. (2020). Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC. Journal of thoracic oncology, 15(5), 816-826. https://doi.org/10.1016/j.jtho.2020.01.017

Chicago Style (17th ed.) Citation

Gao, Shugeng, et al. "Neoadjuvant PD-1 Inhibitor (Sintilimab) in NSCLC." Journal of Thoracic Oncology 15, no. 5 (2020): 816-826. https://doi.org/10.1016/j.jtho.2020.01.017.

MLA (9th ed.) Citation

Gao, Shugeng, et al. "Neoadjuvant PD-1 Inhibitor (Sintilimab) in NSCLC." Journal of Thoracic Oncology, vol. 15, no. 5, 2020, pp. 816-826, https://doi.org/10.1016/j.jtho.2020.01.017.